Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2359]
News [5791]
Articles [142]
Editorials [4]
Conferences [165]
elearning [20]
Updates in the ABC5 guidelines for the treatment of luminal metastatic breast...
Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut...
Updates in the ABC5 guidelines for the treatment of luminal metastatic breast cancer ( Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut, Lebanon )
27 Jan 2020
Current controversies in breast cancer treatment
Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland
Current controversies in breast cancer treatment ( Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland )
27 Jan 2020
Highlights from BGICC 2020
Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from BGICC 2020 ( Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
27 Jan 2020
PARP inhibitors and immunotherapy in ovarian cancer: From research to practice
PARP inhibitors and immunotherapy in ovarian cancer: From research to practice ( )
27 Jan 2020
The age of genomic profiling
Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey
The age of genomic profiling ( Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey )
27 Jan 2020
Identifying BRCA mutations for breast and ovarian cancer
Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus
Identifying BRCA mutations for breast and ovarian cancer ( Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus )
27 Jan 2020
Long-term toxicities in paediatric ALL
Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark
Long-term toxicities in paediatric ALL ( Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark )
23 Jan 2020
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020
Novel therapeutic approaches in B-progenitor ALL
Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA
Novel therapeutic approaches in B-progenitor ALL ( Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020
Latest concepts in frontline therapy for paediatric ALL
Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Latest concepts in frontline therapy for paediatric ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020
Is enasidenib plus azacitidine better than with azacitidine alone for AML...
Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA
Is enasidenib plus azacitidine better than with azacitidine alone for AML patients? ( Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA )
24 Dec 2019
Lenalidomide maintenance for transplant eligible and transplant ineligible...
Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
24 Dec 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation